Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evolving spike-protein N -glycosylation in SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.08.539897Source: DataRank Database

Evolving spike-protein N -glycosylation in SARS-CoV-2 variants is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

uniprot pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jolene K. Diedrich ORCID,Jonathan L. Torres ORCID,Jeffrey Copps ORCID,Bhavya Singh ORCID,Patrick T. Garrett ORCID

Live enrichment

PubMed:37214937 OpenAlex:https://openalex.org/W4376118465

National Institutes of Health

Grant: 3P41GM103533-20S2

Comprehensive Biology: Exploiting the Yeast Genome

National Institutes of Health

Grant: 3UM1AI100663-04S1

Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery

National Institutes of Health

Grant: 2R56AI113867-06

Glycan dependent epitopes of HIV broadly neutralizing antibodies

National Institutes of Health

Grant: 3UM1AI144462-02S1

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antivirals

greenLicense: cc-by-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/12/18/2023.05.08.539897.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.05.08.539897

repositoryhttps://doi.org/10.1101/2023.05.08.539897

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37214937

Fields of Study

SARS-CoV-2 and COVID-19 ResearchBacteriophages and microbial interactionsvaccines and immunoinformatics approaches

Keywords

GlycanSpike (software development)BiologyGlycosylationGlycoproteinImmune systemPopulationImmunitySpike ProteinComputational biologyVirologyGeneticsCoronavirus disease 2019 (COVID-19)MedicineArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Evolving spike-protein N -glycosylation in SARS-CoV-2 variants

FAIR Checklist

Authors (9)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)